Showing posts with label Health Issues. Show all posts
Showing posts with label Health Issues. Show all posts

Saturday, 11 August 2012

Health Issues-Barack Obama-Mitt Romney-Women

Obama hammers Romney on women’s issues at Denver rally

President Barack Obama, campaigning in Denver Wednesday, said opponent Mitt Romney’s views on women’s health issues are “more suited to the 1950s than the 21st century.”Appearing at the downtown Auraria Campus’ event center to open a two-day campaign swing through Colorado, Obama spoke to a mostly-female crowd of about 4,000 behind a sign touting “Women’s Health Security.”“The decisions that affect a woman’s health — they’re not up to politicians; they’re not up to insurance… (Source: bizjournals.com Health Care:Pharmaceuticals headlines) read more..

Wednesday, 4 April 2012

Pharmaceutical Manufacturer-Quality Control Management-Amylin Pharmaceuticals-Nurses' Health Study

Wanted: Female Nurses for Large, Ongoing Study

THURSDAY, March 1 -- Researchers are looking for 100,000 female nurses and nursing students to join the long-running Nurses' Health Study, which has yielded insight into a wide range of health issues, such as the benefits of physical activity and... read more..


Amylin Pharmaceuticals Announces Public Offering of Common Stock

SAN DIEGO, March 7, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that it is offering to sell shares of its common stock in an underwritten public offering.Credit Suisse Securities (USA) LLC is acting as sole book-running manager and underwriter... read more..


AMRI names quality control director for troubled plant, following lead of J&J, Novartis, others

Another pharmaceutical manufacturer has announced that it is beefing up quality control management after running afoul of FDA inspectors. AMRI ($AMRI) has named Tom McGrath as director of quality for aseptic services at its Burlington, MA, facility, which last year was cited in an FDA warning letter. A string of companies including Johnson & Johnson ($JNJ), Novartis ($NVS) and Hospira ($HSP) have recently named new leaders ranging from the plant level to the executive suite, whose focus, at least in part, will be on improving GMP in plants. Release | Story read more..